Suvorexant

Suvorexant, sold under the trade name Belsomra, is a medication for the treatment of insomnia. It is effective for insomnia, at least for four weeks and as compared to a placebo. Suvorexant is a selective, dual orexin receptor antagonist made by Merck & Co.